DOCSLIB.ORG

Curriculum Vitae Prof. Dr. Elisa Izaurralde

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Curriculum Vitae Prof. Dr. Elisa Izaurralde Curriculum Vitae Prof. Dr. Elisa Izaurralde Name: Elisa Izaurralde Geboren: 20. September 1959 Verstorben: 30. April 2018 Forschungsschwerpunkte: Genexpression, RNA-Metabolismus, RNA-Exosom, Röntgen- kristallographie, Kern-Zytoplasma-Transport, mRNA-Abbau Elisa Izaurralde ist Molekularbiologin. Schwerpunkte ihrer Forschung sind Mechanismen der Genexpression und Transportwege in den Zellen. Sie hat einen neuen Transportweg für den Abbau von RNA aus dem Zellkern aufgezeigt und detailliert Mechanismen des RNA-Stoffwechsels beschrieben. Akademischer und beruflicher Werdegang 2005 - 2018 Direktorin und Wissenschaftliches Mitglied am Max-Planck-Institut für Entwicklungsbiologie 2004 - 2006 Senior Scientist am EMBL, Heidelberg 1999 - 2004 Gruppenleiterin im Gene Expression Program, EMBL, Heidelberg 1996 - 1999 Forschungsgruppenleiterin am Institut für Molekularbiologie der Universität Genf 1990 - 1996 Postdoktorandin am European Molecular Biology Laboratory (EMBL), Heidelberg 1989 - 1990 Postdoktorandin an der Universität Genf 1989 Promotion an der Universität Genf Studium der Biochemie in Genf Funktionen in wissenschaftlichen Gesellschaften und Gremien 2016 Mitorganisatorin des Cold Spring Harbor meeting on Non-coding RNAs, Cold Spring Harbor, New York, USA Nationale Akademie der Wissenschaften Leopoldina www.leopoldina.org 1 seit 2015 Vorsitzende des LS1 Advanced Grant Panel des European Research Council 2015 Organisatorin des EMBO-/EMBL-Symposiums: „The non-coding genome”, Heidelberg 2015 Evaluationskomitee des Instituts für Biochemie, Eidgenössische Technische Hochschule (ETH) Zürich 2014 Vorsitzende „Molekular- und Strukturbiologie” im Biochemie-Ausschuss des ATIPE- Avenir Programms, Frankreich 2011 - 2013 Ausschuss-Mitglied der ERC-2011-Advanced Grants 2014 Mitorganisatorin des Cold Spring Harbor meeting on Non-coding RNAs, Cold Spring Harbor, USA seit 2014 Editorial Board „PLOS Biology“ 2013 Organisatorin des EMBO-/EMBL-Symposiums: „The non-coding genome”, Heidelberg 2012 Mitorganisatorin des Cold Spring Harbor meeting on Non-coding RNAs, Cold Spring Harbor, USA 2012 Plenary lecture im EMBO Meeting 2012, Nizza, Frankreich seit 2012 Board of reviewing editors „eLife“ 2011 L'Oreal Plenary Lecture im 34th Congress of the Spanish Society for Biochemistry and Molecular Biology (SEBBM), Barcelona, Spanien 2011 Organisatorin des Keystone Symposiums, Mechanism and Biology of Silencing, Monterey, Kalifornien, USA seit 2011 Editor „RNA“ 2010 Organisatorin des EMBO-/EMBL-Symposiums: „The non-coding genome”, Heidelberg seit 2009 Wissenschaftlicher Beirat des Max-Delbrück-Centrums für Molekulare Medizin (MDC), Berlin seit 2007 Advisory Editorial Board des „EMBO Journal“ seit 2007 Advisory Editorial Board der „EMBO Reports“ 2007 - 2011 Editor „FEBS Journal“ 2006 - 2009 Editorial Board „Molecular and Cellular Biology“ 2006 - 2009 Highlights Advisory Panel für „Nature Reviews Molecular Cell Biology“ seit 2005 Gutachterausschuss für unabhängige Max-Planck-Juniorforschungsgruppen 2005 - 2011 Editorial Board „RNA“ 2005 - 2009 Gutachterausschuss des EMBO Young Investigator Program 2004 - 2010 Editorial Board „European Journal of Cell Biology“ Nationale Akademie der Wissenschaften Leopoldina www.leopoldina.org 2 2004 - 2006 Programmkoordinatorin des Gene Expression Program, EMBL, Heidelberg 2003 - 2008 Gutachterausschuss für ATIPE-Stipendien, Frankreich 2001 - 2005 Gutachterkomitee für HFSPO-Langzeit-Stipendien Projektkoordination, Mitgliedschaft in Verbundprojekten 2007 - 2014 DFG-Projekt „Role of GW182 proteins in miRNA-mediated gene silencing”, Teilprojekt zu FOR 855 „Cytoplasmic regulation of gene expression” Auszeichnungen und verliehene Mitgliedschaften seit 2016 Mitglied der Academia Europaea 2012 Ernst-Jung-Preis seit 2009 Mitglied der Nationalen Akademie der Wissenschaften Leopoldina 2008 Gottfried-Wilhelm-Leibniz Preis der DFG (gemeinsam mit Elena Conti) 2004 Mitglied im Board of Directors der RNA Society 2000 Young Scientist Award der European Life Science Organization (ELSO) 2000 Mitglied der European Molecular Biology Organization (EMBO) 1999 Friedrich Miescher-Preis, Schweizerische Gesellschaft für Biochemie Forschungsschwerpunkte Elisa Izaurralde ist Molekularbiologin. Schwerpunkte ihrer Forschung sind Mechanismen der Genexpression und Transportwege in den Zellen. Sie hat einen neuen Transportweg für den Export von RNA aus dem Zellkern aufgezeigt und detailliert Mechanismen des RNA-Stoffwechsels beschrieben. Elisa Izaurralde erforscht, wie Proteine und RNA-Moleküle (Ribonukleinsäure) zusammenwirken und wie dadurch in der Zelle grundlegende Prozesse reguliert werden, wie beispielsweise das Verarbeiten von genetischer Information (Genexpression), die Zellteilung und die Signalweiterleitung. RNA- Moleküle kommen in großer Zahl in der Zelle vor, sie übermitteln genetische Informationen und regulieren Gene. Nicht benötigte oder defekte RNAs müssen in der Zelle entsorgt werden. Elisa Izaurralde hat einen neuen Transportweg für den Export der Boten-RNA aus dem Zellkern identifiziert und den Abbauweg für fehlerhafte Boten-RNA-Moleküle im Detail beschrieben. Ein wesentlicher Teilprozess der Genexpression ist die Entstehung von RNA anhand einer DNA- Vorlage (Transkription). Lange wurde angenommen, dass die Genexpression hauptsächlich auf der Transkriptionsebene reguliert wird. Inzwischen ist bekannt, dass es auch nach der Transkription Nationale Akademie der Wissenschaften Leopoldina www.leopoldina.org 3 Mechanismen gibt, mit denen Zellen Gene regulieren. Eliza Izaurralde untersucht mit ihrem Team solche Post-Transkriptionsprozesse (mRNA-Verarbeitung, Export, Überwachung, Silencing, Umsatz). Die Prozesse sind miteinander verknüpft und bilden ein komplexes Netzwerk, das Gene reguliert und zu spezifischen Genexpressionsmustern beiträgt. Mit ihrer Forschung möchte Elisa Izaurralde weiter aufklären, wie die Netzwerke auf der posttranskriptionalen Ebene miteinander und mit verschiedenen zellulären Prozessen verbunden sind. Ihr Ziel ist es, die Rolle der posttranskriptionellen Prozesse bei der Genexpression aufzuzeigen und zu verstehen, was passiert, wenn diese Prozesse gestört sind. Nationale Akademie der Wissenschaften Leopoldina www.leopoldina.org 4 .
Load more

Recommended publications
  • EMBC Annual Report 2007
    EMBO | EMBC annual report 2007 EUROPEAN MOLECULAR BIOLOGY ORGANIZATION | EUROPEAN MOLECULAR BIOLOGY CONFERENCE EMBO | EMBC table of contents introduction preface by Hermann Bujard, EMBO 4 preface by Tim Hunt and Christiane Nüsslein-Volhard, EMBO Council 6 preface by Marja Makarow and Isabella Beretta, EMBC 7 past & present timeline 10 brief history 11 EMBO | EMBC | EMBL aims 12 EMBO actions 2007 15 EMBC actions 2007 17 EMBO & EMBC programmes and activities fellowship programme 20 courses & workshops programme 21 young investigator programme 22 installation grants 23 science & society programme 24 electronic information programme 25 EMBO activities The EMBO Journal 28 EMBO reports 29 Molecular Systems Biology 30 journal subject categories 31 national science reviews 32 women in science 33 gold medal 34 award for communication in the life sciences 35 plenary lectures 36 communications 37 European Life Sciences Forum (ELSF) 38 ➔ 2 table of contents appendix EMBC delegates and advisers 42 EMBC scale of contributions 49 EMBO council members 2007 50 EMBO committee members & auditors 2007 51 EMBO council members 2008 52 EMBO committee members & auditors 2008 53 EMBO members elected in 2007 54 advisory editorial boards & senior editors 2007 64 long-term fellowship awards 2007 66 long-term fellowships: statistics 82 long-term fellowships 2007: geographical distribution 84 short-term fellowship awards 2007 86 short-term fellowships: statistics 104 short-term fellowships 2007: geographical distribution 106 young investigators 2007 108 installation
    [Show full text]
  • Dissertation
    Regulation of gene silencing: From microRNA biogenesis to post-translational modifications of TNRC6 complexes DISSERTATION zur Erlangung des DOKTORGRADES DER NATURWISSENSCHAFTEN (Dr. rer. nat.) der Fakultät Biologie und Vorklinische Medizin der Universität Regensburg vorgelegt von Johannes Danner aus Eggenfelden im Jahr 2017 Das Promotionsgesuch wurde eingereicht am: 12.09.2017 Die Arbeit wurde angeleitet von: Prof. Dr. Gunter Meister Johannes Danner Summary ‘From microRNA biogenesis to post-translational modifications of TNRC6 complexes’ summarizes the two main projects, beginning with the influence of specific RNA binding proteins on miRNA biogenesis processes. The fate of the mature miRNA is determined by the incorporation into Argonaute proteins followed by a complex formation with TNRC6 proteins as core molecules of gene silencing complexes. miRNAs are transcribed as stem-loop structured primary transcripts (pri-miRNA) by Pol II. The further nuclear processing is carried out by the microprocessor complex containing the RNase III enzyme Drosha, which cleaves the pri-miRNA to precursor-miRNA (pre-miRNA). After Exportin-5 mediated transport of the pre-miRNA to the cytoplasm, the RNase III enzyme Dicer cleaves off the terminal loop resulting in a 21-24 nt long double-stranded RNA. One of the strands is incorporated in the RNA-induced silencing complex (RISC), where it directly interacts with a member of the Argonaute protein family. The miRNA guides the mature RISC complex to partially complementary target sites on mRNAs leading to gene silencing. During this process TNRC6 proteins interact with Argonaute and recruit additional factors to mediate translational repression and target mRNA destabilization through deadenylation and decapping leading to mRNA decay.
    [Show full text]
  • The GW182 Protein Family in Animal Cells: New Insights Into Domains Required for Mirna-Mediated Gene Silencing
    Downloaded from rnajournal.cshlp.org on September 30, 2021 - Published by Cold Spring Harbor Laboratory Press REVIEW The GW182 protein family in animal cells: New insights into domains required for miRNA-mediated gene silencing ANA EULALIO, FELIX TRITSCHLER, and ELISA IZAURRALDE Department of Biochemistry, Max Planck Institute for Developmental Biology, D-72076 Tu¨bingen, Germany ABSTRACT GW182 family proteins interact directly with Argonaute proteins and are required for miRNA-mediated gene silencing in animal cells. The domains of the GW182 proteins have recently been studied to determine their role in silencing. These studies revealed that the middle and C-terminal regions function as an autonomous domain with a repressive function that is independent of both the interaction with Argonaute proteins and of P-body localization. Such findings reinforce the idea that GW182 proteins are key components of miRNA repressor complexes in metazoa. Keywords: Argonaute; GW182; miRNAs; mRNA decay; P-bodies; RBD; RRM; TNRC6A INTRODUCTION are conserved in diverse organisms (for review, see Carthew and Sontheimer 2009; Kim et al. 2009). Among proteins MicroRNAs are genome-encoded small RNAs that post- that play a general role, those in the GW182 family have transcriptionally regulate gene expression and play critical emerged as key components of miRNA repressive com- roles in a wide range of important biological processes plexes in animal cells (for review, see Ding and Han 2007; including cell growth, division and differentiation, and Eulalio et al. 2007a, 2008a). organism metabolism and development. About 500–1000 The precise molecular function of GW182 proteins in the miRNA genes exist in vertebrates and plants, and 100 in miRNA pathway is not fully understood; yet, recent studies invertebrates, and each miRNA is predicted to have target have provided new insights into their role in silencing sites in hundreds of mRNAs, suggesting that miRNAs (Chekulaeva et al.
    [Show full text]
  • Awarded the 2014 Louis-Jeantet Prize for Medicine
    PRESS RELEASE Geneva, January 21, 2014 2014 LOUIS-JEANTET PRIZE FOR MEDICINE The 2014 LOUIS-JEANTET PRIZE FOR MEDICINE is awarded to the Italian biochemist Elena Conti, Director of the Department of Structural Cell Biology at the Max-Planck Institute of Biochemistry in Munich (Germany) and to Denis Le Bihan, the French medical doctor, physicist and Director of NeuroSpin, an institute at the French Nuclear and Renewable Energy Commission (CEA) at Saclay near Paris. The LOUIS-JEANTET FOUNDATION grants the sum of CHF 700'000 for each of the two 2014 prizes, of which CHF 625'000 is for the continuation of the prize-winner's work and CHF 75’000 for their personal use. THE PRIZE-WINNERS are conducting fundamental biological research which is expected to be of considerable significance for medicine. ELENA CONTI is awarded the 2014 Louis-Jeantet Prize for Medicine for her important contributions to understanding the mechanisms governing ribonucleic acid (RNA) quality, transport and degradation. In order to function properly, our cells need to degrade macromolecules that are faulty or no longer needed. The biochemist deciphered at the level of atomic resolution how faulty RNAs are recognized and eliminated. Notably, her group deciphered the three-dimensional architecture and molecular mechanisms of the exosome, a multiprotein complex that recognizes and degrades RNAs. The work revealed that several principles of the mechanism of this essential nano-machine are conserved in different forms of life. Elena Conti will use the prize money to conduct further research into the structure and regulation of the exosome. DENIS LE BIHAN is awarded the 2014 Louis-Jeantet Prize for Medicine for the development of a new imaging method that has revolutionized the diagnosis and treatment of strokes.
    [Show full text]
  • New Heads of Units for EMBL Heidelberg Council
    40 EMBL August 2007 &Newslettercetera of the European Molecular Biology Laboratory Council Meeting: Australia to join as associate member state Delegates at this summer’s EMBL Council meeting in Hamburg agreed that Australia will become EMBL’s first associate member state. The associate membership is planned to officially start in January next year and will initially last for seven years. Other news from the meeting includes Luxembourg’s ratification to become EMBL’s 20th full member state, the appointment of Anne Ephrussi as the new Unit Coordinator for Developmental Biology, Detlev Arendt’s promotion to Senior Scientist and much more. pages 2 and 3 New heads of units for EMBL Heidelberg Following the departure at the end of last year of Structural and Computational Biology Unit coordi- nator Luis Serrano to the Center for Genomic Regulation in Barcelona, former Deputy Head of EMBL Grenoble Christoph Müller (right) arrived at EMBL Heidelberg at the start of August to fill his shoes as Joint Coordinator alongside Peer Bork. In addition, Anne Ephrussi has been appointed as the new Unit Coordinator for Developmental Biology. Inside, both talk about their plans for the units. pages 2 and 3 EMBL-EBI throws open the doors to training facilities Next time you pay a visit to EMBL-EBI, take a look at their new IT training suite, part of the newly com- pleted East Wing. It’s where visitors will receive tuition in the EBI’s bioinformatics resources at its Genome Campus location for the first time. With 40 permanent workstations and the option to dou- ble the room’s capacity for an additional 40 laptop-based users, the state-of-the-art suite also features touchscreen audio-visual controls, window blinds and lights.
    [Show full text]
  • CV Elena Conti
    Curriculum Vitae Prof. Dr. Elena Conti Name: Elena Conti Foto: Axel Griesch Forschungsschwerpunkte: RNA Metabolismus, RNA Exosom, Exon-Junction-Komplex, Röntgenkristallographie, zelluläre Strukturbiologie, Kern-Zytoplasma-Transport, mRNA Abbau Elena Conti ist eine italienische Molekularbiologin am Max-Planck-Institut für Biochemie in Martinsried, die grundlegende neue Erkenntnisse zum RNA-Transport innerhalb der Zelle und zum RNA-Stoffwechsel entschlüsselte. Elena Conti begann ihre wissenschaftliche Laufbahn zunächst als Röntgenstrukturanalytikerin. Am Europäischen Laboratorium für Molekularbiologie (EMBL) in Heidelberg untersuchte sie dann vor allem die strukturellen Aspekte des RNA-Transports innerhalb der Zelle. Akademischer und beruflicher Werdegang seit 2007 Honorarprofessorin, Chemie und Pharmakologie, Ludwig-Maximilians-Universität München seit 2006 Direktorin und Wissenschaftliches Mitglied am Max-Planck-Institut für Biochemie, Abteilung Strukturelle Zellbiologie, Martinsried 1999 - 2007 Gruppenleiterin European Molecular Biology Laboratory (EMBL), Heidelberg, Structural and Computational Biology Unit 1999 - 2005 gemeinsame Berufung mit der Gene Expression Unit, EMBL 1997 - 1999 Postdoc-Aufenthalt bei Prof. Dr. John Kuriyan, The Rockefeller University, New York, USA 1996 Promotion bei Prof. Dr. Peter Brick, Imperial College of Science, Technology and Medicine, London, UK, „Crystal structure of firefly luciferase” 1992 - 1996 Doktorandin in Biophysik am Imperial College, London, UK Funktionen in wissenschaftlichen Gesellschaften
    [Show full text]
  • Program Information
    RNA 2021 The 26th Annual Meeting of the RNA Society On-line May 25–June 4, 2021 RNA 2021 On-Line The 26th Annual Meeting of the RNA Society CORRECT THE MESSAGE CHANGE A LIFETM Locanabio’s CORRECTXTM platform is pioneering a new class of gene therapies by correcting the th th May 25 – June 4 , 2021 dysfunctional RNA that causes a broad range of neurodegenerative, neuromuscular and retinal diseases Gene Yeo – University of California San Diego, USA Katrin Karbstein – Scripps Research Institute, Florida, USA V. Narry Kim – Seoul National University, South Korea Anna Marie Pyle – Yale University, USA Xavier Roca – Nanyang Technological University, Singapore Jörg Vogel – University of Würzburg, Germany RNA 2021 • On-line GENERAL INFORMATION Citation of abstracts presented during RNA 2021 On-line (in bibliographies or other) is strictly prohibited. Material should be treated as personal communication and is to be cited only with the expressed written ® consent of the author(s). The Sequel IIe System NO UNAUTHORIZED PHOTOGRAPHY OF ANY MATTER PRESENTED DURING THE ON-LINE MEETING: To encourage sharing of unpublished data at the RNA Society Annual Meeting, taking of photographs, screenshots, videos, and/or downloading or saving Reveal the functional e ects any material is strictly prohibited. of alternative splicing with USE OF SOCIAL MEDIA: The official hash tag of the 26th Annual Meeting of the RNA Society is full-length transcript sequencing #RNA2021. The organizers encourage attendees to tweet about the amazing science they experience during the meeting. However, please respect these few simple rules when using the #RNA2021 hash tag, or when talking about the meeting on Twitter and other social media platforms: 1.
    [Show full text]
  • The Myth of Junk DNA
    The Myth of Junk DNA JoATN h A N W ells s eattle Discovery Institute Press 2011 Description According to a number of leading proponents of Darwin’s theory, “junk DNA”—the non-protein coding portion of DNA—provides decisive evidence for Darwinian evolution and against intelligent design, since an intelligent designer would presumably not have filled our genome with so much garbage. But in this provocative book, biologist Jonathan Wells exposes the claim that most of the genome is little more than junk as an anti-scientific myth that ignores the evidence, impedes research, and is based more on theological speculation than good science. Copyright Notice Copyright © 2011 by Jonathan Wells. All Rights Reserved. Publisher’s Note This book is part of a series published by the Center for Science & Culture at Discovery Institute in Seattle. Previous books include The Deniable Darwin by David Berlinski, In the Beginning and Other Essays on Intelligent Design by Granville Sewell, God and Evolution: Protestants, Catholics, and Jews Explore Darwin’s Challenge to Faith, edited by Jay Richards, and Darwin’s Conservatives: The Misguided Questby John G. West. Library Cataloging Data The Myth of Junk DNA by Jonathan Wells (1942– ) Illustrations by Ray Braun 174 pages, 6 x 9 x 0.4 inches & 0.6 lb, 229 x 152 x 10 mm. & 0.26 kg Library of Congress Control Number: 2011925471 BISAC: SCI029000 SCIENCE / Life Sciences / Genetics & Genomics BISAC: SCI027000 SCIENCE / Life Sciences / Evolution ISBN-13: 978-1-9365990-0-4 (paperback) Publisher Information Discovery Institute Press, 208 Columbia Street, Seattle, WA 98104 Internet: http://www.discoveryinstitutepress.com/ Published in the United States of America on acid-free paper.
    [Show full text]
  • Nucleus and Gene Expression Editorial Overview Elisa Izaurralde and Phillip D Zamore
    Available online at www.sciencedirect.com Nucleus and gene expression Editorial overview Elisa Izaurralde and Phillip D Zamore Current Opinion in Cell Biology 2009, 21:331–334 Available online 14th May 2009 0955-0674/$ – see front matter # 2009 Elsevier Ltd. All rights reserved. DOI 10.1016/j.ceb.2009.04.013 Elisa Izaurralde That most information flows from DNA through RNA to protein remains the Department of Biochemistry, Max-Planck- organizing principle of modern molecular biology. Thus we begin this issue Institute for Developmental Biology, with an introduction to DNA replication by Mike O’Donnell and Nina Yao. Spemannstrasse 35, D-72076 Tu¨ bingen, Germany They describe the composition and function of the replisome, the machine e-mail: [email protected] that organizes activities at the replication fork, highlighting the unique challenges solved in the evolution of DNA replication proteins. Not only Elisa Izaurralde leads the does the replisome coordinate DNA copying on the leading and lagging Department of Biochemistry at the strands, it also allows the replication apparatus to skip over DNA lesions and Max Planck Institute for to pass a transcribing RNA polymerase without interrupting either tran- Developmental Biology in Tu¨ bingen, scription or replication. Germany. Her research focuses on the molecular mechanisms that Initiating transcription at the right place, at the right time, and in the right regulate gene expression at the cells is, of course, the primary challenge of gene regulation. Timothy post-transcriptional level, with Sikorski and Stephen Buratowski identify a key paradox in initiating mRNA particular emphasis on mRNA transcription: a conserved set of transcription initiation proteins are used to surveillance, decay, and silencing in recruit a common RNA polymerase, RNA Pol II, to many different tran- scription initiation sequences (promoters).
    [Show full text]
  • P-Body Formation Is a Consequence, Not the Cause, of RNA-Mediated Gene Silencing Ana Eulalio, Isabelle Behm-Ansmant, Daniel Schweizer, Elisa Izaurralde
    P-Body Formation Is a Consequence, Not the Cause, of RNA-Mediated Gene Silencing Ana Eulalio, Isabelle Behm-Ansmant, Daniel Schweizer, Elisa Izaurralde To cite this version: Ana Eulalio, Isabelle Behm-Ansmant, Daniel Schweizer, Elisa Izaurralde. P-Body Formation Is a Consequence, Not the Cause, of RNA-Mediated Gene Silencing. Molecular and Cellular Biology, American Society for Microbiology, 2007, 27 (11), pp.3970-3981. 10.1128/MCB.00128-07. hal- 01738446 HAL Id: hal-01738446 https://hal.archives-ouvertes.fr/hal-01738446 Submitted on 20 Mar 2018 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. MOLECULAR AND CELLULAR BIOLOGY, June 2007, p. 3970–3981 Vol. 27, No. 11 0270-7306/07/$08.00ϩ0 doi:10.1128/MCB.00128-07 Copyright © 2007, American Society for Microbiology. All Rights Reserved. P-Body Formation Is a Consequence, Not the Cause, of RNA-Mediated Gene Silencingᰔ† Ana Eulalio, Isabelle Behm-Ansmant, Daniel Schweizer, and Elisa Izaurralde* MPI for Developmental Biology, Spemannstrasse 35, D-72076 Tu¨bingen, Germany Received 19 January 2007/Returned for modification 16 February 2007/Accepted 19 March 2007 P bodies are cytoplasmic domains that contain proteins involved in diverse posttranscriptional processes, such as mRNA degradation, nonsense-mediated mRNA decay (NMD), translational repression, and RNA- mediated gene silencing.
    [Show full text]
  • Wednesday 09 October 2013 14:00 - 16:45 Arrival and Registration ATC Foyer
    Programme Wednesday 09 October 2013 14:00 - 16:45 Arrival and registration ATC Foyer 16:45 - 17:00 Welcome ATC Auditorium 17:00 - 20:15 Session 1: The diversity of non-coding RNAs Chair: Elisa Izaurralde ATC Auditorium 17:00 - 17:30 Central roles of bacterial RNAs in regulating 1 metabolism Gisela Storz NICHD, NIH, United States of America 17:30 - 18:00 RNA: protein interactions 2 Nikolaus Rajewsky Max Delbrück Center for Molecular Medicine, Germany 18:00 - 18:15 Natural RNA circles function as efficient miRNA 3 sponges Thomas Hansen Aarhus University, Denmark 18:15 - 18:45 Coffee Break ATC Foyer 18:45 - 19:15 The human genome as the zip file extraordinaire 4 John Mattick Garvan Institute of Medical Research, Australia 19:15 - 19:45 RNA silencing and epigenetics in plants 5 David Baulcombe University of Cambridge, United Kingdom 19:45 - 20:00 Cross-talking noncoding RNAs confer central 6 nervous system specificity to Spinocerebellar Ataxia 7 pathology Ana Marques University of Oxford, United Kingdom EMBO|EMBL Symposium The Non-Coding Genome 20:00 - 20:15 A long non coding RNA regulates chromatin mediated 7 modulation of alternative splicing Reini Luco IGH-CNRS, France 20:15 - 23:00 Dinner Canteen Page 6 Programme Thursday 10 October 2013 09:00 - 12:15 Session 2: miRNA function and mechanisms Chair: David P. Bartel ATC Auditorium 09:00 - 09:30 The roles of long noncoding RNA in epigenetic 8 regulation Jeannie Lee Massachusetts General Hospital, United States of America 09:30 - 10:00 3’ end modifications in the MicroRNA pathway 9 V.
    [Show full text]
  • Timothy W. Nilsen Eric Phizicky Thomas R. Cech
    ISSN 1355-8382 EDITOR IN CHIEF DEPUTY EDITOR REVIEWS EDITOR Timothy W. Nilsen Eric Phizicky Thomas R. Cech Case Western Reserve University University of Rochester School Howard Hughes Medical Institute of Medicine and Dentistry EDITORS Javier F. Caceres Elisa Izaurralde Peter F. Stadler MRC Human Genetics Unit Max Planck Institute for Developmental Biology, Tuebingen Leipzig University Kathleen Collins Daniel Kolakofsky Gisela Storz University of California, Berkeley University of Geneva National Institute of Child Health and Elena Conti Human Development Max Planck Institute of Biochemistry, Marina V. Rodnina Max Planck Institute for Biophysical Chemistry Eric Westhof Martinsried CNRS, Strasbourg Adrian R. Ferré-D’Amaré Rob Singer Albert Einstein School of Medicine John Woolford National Heart, Lung and Blood Institute Carnegie Mellon University Brenton R. Graveley Erik Sontheimer University of Connecticut Health Center University of Massachusetts Medical School EDITORIAL BOARD John N. Abelson Martha J. Fedor Thomas Maniatis Phillip A. Sharp California Institute of Technology The Scripps Research Institute Harvard University Massachusetts Institute of Technology Sidney Altman Witold Filipowicz James Manley Joan A. Steitz Yale University Friedrich Miescher Institute Columbia University Yale University Mariano A. Garcia-Blanco Scott Strobel Manuel Ares Lynne E. Maquat Yale University University of California, Santa Cruz Duke University University of Rochester David Tollervey David P. Bartel Christine Guthrie Iain W. Mattaj University of Edinburgh Massachusetts Institute of Technology University of California, San Francisco EMBL, Heidelberg Thomas Tuschl Brenda L. Bass Matthias W. Hentze William H. McClain The Rockefeller University University of Utah EMBL, Heidelberg University of Wisconsin, Madison Olke C. Uhlenbeck Daniel Herschlag Northwestern University Philip C.
    [Show full text]